Light-Sensitive Injectable Prescription Drugs-2022.

Area of Science:

• Pharmacology
• Drug Stability
• Pharmaceutical Compounding

Background:

• Injectable medications are susceptible to degradation when exposed to light.
• Previous guidelines on light-protected injectable drugs were published in 2014.
• Maintaining drug integrity is vital for therapeutic outcomes and patient safety.

Purpose of the Study:

• To update the existing chart of injectable drugs requiring protection from light.
• To provide current information on light-sensitive injectable medications.
• To aid healthcare professionals in proper drug handling and storage.

Main Methods:

• Conducted an online search of the FDA Label database (inception to July 31, 2022) using "protect" OR "light."
• Filtered results to include only injectable drugs.
• Combined new findings with a 2014 list, removed duplicates, and reviewed drug requirements for light protection during storage, preparation, or administration.

Main Results:

• Identified a comprehensive list of injectable drugs that require protection from light.
• The updated list reflects current FDA labeling information.
• The chart serves as a reference for identifying light-sensitive injectable medications.

Conclusions:

• Accurate identification of injectable drugs requiring light protection is essential for clinical practice.
• This updated resource assists in preventing drug degradation and ensuring treatment efficacy.
• Healthcare providers must consult official prescribing information for definitive guidance on light protection for injectable drugs.